QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HCA

QT58HCA Healthcare, Inc.
NYSE·Healthcare·Medical - Care Facilities·USA
Latest market price
375.17
-12.99-3.35%
OverviewShort InterestFilings
HCAQT58HCA Healthcare, Inc.·NYSE
OverviewShort InterestFilings
375.17-3.35%
TA
Loading chart...
Screen all →
THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17CHE+0.06%$436.27
Snapshot
Index-P/E12.95EPS (ttm)29.08
Insider Own-
Shs Outstand221.84M
Perf Week-0.88%
Market Cap86.11BForward P/E11.30EPS next Y33.19Insider Trans0.09%Shs Float-Perf Month-7.29%
Enterprise Value135.01BPEG0.45EPS next Q7.37Inst Own-Short Float-Perf Quarter-24.92%
Income6.65BP/S1.13EPS this Y3.77%Inst Trans-Short Ratio-Perf Half Y-20.14%
Sales76.39BP/B-EPS next Y9.99%ROA11.06%Short Interest-Perf YTD-19.64%
Book/sh-13.42P/C6.77EPS next 5Y12.73%ROE-123.20%52W High556.55 -32.59%Perf Year0.73%
Cash/sh4.24P/FCF10.86EPS past 3/5Y-ROIC18.84%52W Low329.99 13.69%Perf 3Y-
Dividend Est.3.00 (0.80%)EV/EBITDA8.62Sales past 3/5Y7.87% 7.97%Gross Margin34.92%Volatility2.03% 1.98%Perf 5Y-
Dividend TTM3.00 (0.80%)EV/Sales1.77EPS Y/Y TTM31.64%Oper. Margin15.67%ATR (14)11.76Perf 10Y-
Dividend Ex-DateJun 16, 2026Quick Ratio0.75Sales Y/Y TTM8.19%Profit Margin8.89%RSI (14)39.48Recom2.54
Dividend Gr. 3/5Y8.74% 30.19%Current Ratio0.83EPS Q/Q10.85%SMA20-1.21%Beta0.21Target Price504.73
Payout10.04%Debt/Eq-7.91Sales Q/Q4.30%SMA50-10.99%Rel Volume1.75Prev Close388.16
Employees320,000LT Debt/Eq-15.68EarningsJul 24SMA200-18.54%Avg Volume1.49MPrice375.17
IPO DateMar 10, 2011Option/ShortYes / YesEPS/Sales Surpr.0.42% 0.11%Net Debt/EBITDA3.12Volume2,607,831Change-3.35%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-04-26ReiteratedTruist Financial$535 → $413
Jun-04-26ReiteratedBernsteinMarket Perform$541 → $413
Apr-27-26ReiteratedStephens$560 → $530
Apr-27-26ReiteratedTruist Financial$546 → $535
Apr-27-26ReiteratedBarclaysOverweight$551 → $496
Apr-27-26ReiteratedRBC CapitalOutperform$555 → $534
Apr-27-26ReiteratedWells FargoEqual Weight$481 → $436
Apr-27-26ReiteratedKeybancOverweight$503 → $510
Apr-27-26ReiteratedOppenheimerOutperform$540 → $520
Apr-24-26ReiteratedJefferiesBuy$590 → $525
Latest News
Jun-16-26
Jun-16-2610:57AM
1 S&P 500 Stock on Our Buy List and 2 We Brush OffYahoo
Jun-15-26
Jun-15-2605:00PM
Here's How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 YearsBenzinga
01:50PM
Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitYahoo
Jun-11-26
Jun-11-2611:04PM
Is HCA Healthcare Stock A Trap Or A Missed Opportunity?Yahoo
01:03PM
Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027Yahoo
01:03PM
Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027Yahoo
12:17PM
HCA Healthcare Expands Into Education And India As Valuation Gap WidensYahoo
12:17PM
HCA Healthcare Expands Into Education And India As Valuation Gap WidensYahoo
Jun-10-26
Jun-10-2602:00PM
Likely Sector ETF & Stock Winners From May Jobs ReportYahoo
02:00PM
Likely Sector ETF & Stock Winners From May Jobs ReportYahoo
Jun-09-26
Jun-09-2605:41PM
HCA Healthcare (HCA) Announces Agreement to Acquire The College of Health Care ProfessionsYahoo
10:27AM
Michael Burry Loads Up On HCA, Says Selloff Created A Buying Opportunity — ‘Insanely Efficient Compounder'Yahoo
10:27AM
Michael Burry Loads Up On HCA, Says Selloff Created A Buying Opportunity — ‘Insanely Efficient Compounder'Yahoo
Jun-08-26
Jun-08-2604:35PM
These S&P500 stocks are moving in today's sessionChartMill
04:35PM
These S&P500 stocks are moving in today's sessionChartMill
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue76,38875,60070,603
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A49,71144,22641,925
Gross Profit26,67731,37428,678
Selling, General and Administrative Excl. Other16,1447,99731,170
Research and Development
000
Other Operating Expense-1,44011,412-13,039
Operating Income11,97311,96510,547
Interest Expense2,2852,2482,061
Unusual Expense
———
Non-Operating Income (Expense)-104-115-37
Net Income Before Taxes9,7929,8328,523
Income Taxes1,9782,0501,866
Consolidated Net Income6,7946,7845,760
Net Income From Continuing Operations7,8147,7826,657
Net Income6,7946,7845,760
EPS (Recurring)29.2528.6222.27
EPS (Basic, Before Extraordinaries)29.2528.6222.27
EPS (Diluted)29.0828.3822.00
EBITDA15,67015,60313,896
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio12.9016.45—
Price To Sales Ratio1.111.43—
Gross Margin34.9241.5040.62
Operating Margin15.6715.8314.94
Net Margin8.898.978.16
Shares Outstanding227231259
Market Capitalization85,164107,845—
Operating Lease Expense
———
Insider Trading Volume
$434.55$400.92$367.30$333.68$300.05● Close Price0.00M7.32M14.64M21.96M29.28MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 18 '26Sale533.371,694903,5378,853Feb 18 12:00 AM
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 13 '26Option Exercise236.6110,0002,366,10013,853Feb 18 12:00 AM
Berres JenniferSVP & Chief Human Res. OfficerFeb 11 '26Sale514.588,0204,126,95011,993Feb 12 12:00 AM
Wyatt Christopher F.SVP & ControllerFeb 11 '26Sale505.004,0002,020,00044,379Feb 12 12:00 AM
Wyatt Christopher F.SVP & ControllerFeb 05 '26Option Exercise139.0621,3402,967,54051,737Feb 09 12:00 AM
Foster Jon MEVP and COOFeb 05 '26Option Exercise139.0658,6608,157,26029,330Feb 09 12:00 AM
HAZEN SAMUEL NCEOFeb 03 '26Sale501.0442,87721,483,27532,276Feb 05 12:00 AM
Cuffe Michael S.EVP and Chief Clinical OfficerFeb 03 '26Sale498.091,500747,13530,003Feb 05 12:00 AM
HAZEN SAMUEL NCEOJan 30 '26Option Exercise81.96168,72013,828,292116,636Feb 02 12:00 AM
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 05 '25Sale473.793,8921,843,9913,487Nov 05 12:00 AM
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 03 '25Option Exercise236.6126,3406,232,30816,657Nov 05 12:00 AM
HAZEN SAMUEL NCEOOct 31 '25Option Exercise69.58116,1008,078,23875,279Nov 04 12:00 AM
Cuffe Michael S.EVP and Chief Clinical OfficerSep 08 '25Sale418.843,8361,606,67031,503Sep 08 12:00 AM
Cuffe Michael S.EVP and Chief Clinical OfficerSep 04 '25Option Exercise173.1221,8403,780,94042,423Sep 08 12:00 AM
Foster Jon MEVP and COOMay 13 '25Sale369.3215,6985,797,66112,646May 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR